LC–MS/MS and NMR Characterization of Key Impurities in Linagliptin and Pramipexole

References

• FDA Approves Type 2 Diabetes Drug from Boehringer Ingelheim and Lilly. 3 May 2011.
   Google Scholar
• Four Phase III Trials Confirm Benefits of BI’s Oral, Once-Daily Type 2 Diabetes Therapy. Genet. Eng. Biotechnol. News. 2010.
   Google Scholar
• Spreitzer, H. Neue Wirkstoffe - BI-1356 (in German). Österreichische Apothekerzeitung(18/2008). 2008, 918.
   Google Scholar
• Wang, Y.; Serradell, N.; Rosa, E.; Castaner, R. BI-1356. Drugs Future 2008, 33(6), 473–477.
   Web of Science ®Google Scholar
• Once-daily MIRAPEX ER now approved by FDA for both early and advanced Parkinson’s disease. Boehringer Ingelheim Pharmaceuticals, Inc. Retrieved 19 December 2013.
   Google Scholar
• National Prescribing Service. (2009). Pramipexole for Parkinson’s Disease. Medicines Update. http://www.nps.org.au/consumers/publications/medicine_update/issues/Pramipexole_for_Parkinsons_disease.
   Google Scholar
• Kvernmo, T.; Härtter, S.; Burger, E. A Review of the Receptor-Binding and Pharmacokinetic Properties of Dopamine Agonists. Clin. Ther. 2006, 28(8), 1065–78.
   PubMed Web of Science ®Google Scholar
• Newman-Tancredi, A.; Cussac, D.; Audinot, V.; et al. Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D(2)-like Receptor and alpha(1)/alpha(2)-adrenoceptor. J. Pharm. Exp. Ther. 2002, 303(2), 805–14. doi:10.1124/jpet.102.039875. PMID 12388667.
   PubMed Web of Science ®Google Scholar
• Millan, M. J.; Maiofiss, L.; Cussac, D.; Audinot, V.; Boutin, J. A.; Newman-Tancredi, A. Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes. J. Pharm. Exp. Ther. 2002, 303(2), 791–804. doi:10.1124/jpet.102.039867. PMID 12388666.
   PubMed Web of Science ®Google Scholar
• Weber, M.; Chang, W.; Breier, M.; Ko, D.; Swerdlow, N. R. Heritable Strain Differences in Sensitivity to the Startle Gating-Disruptive Effects of D2 but not D3 Receptor Stimulation. Behav. Pharmacol. 2008, 19(8), 786–795. doi:10.1097/FBP.0b013e32831c3b2b. PMC 3255557. PMID 19020413.
   PubMed Web of Science ®Google Scholar
• Chang, W.; Weber, M.; Breier, M. R.; Saint Marie, R. L.; Hines, S. R.; Swerdlow, N. R. Stereochemical and Neuroanatomical Selectivity of Pramipexole Effects on Sensorimotor Gating in Rats. Brain Res. 2012, 1437, 69–76. doi:10.1016/j.brainres.2011.12.007. PMID 22227455.
   PubMed Web of Science ®Google Scholar
• Alsante, K. M.; Friedmann, R. C.; Hatajik, T. D.; Lohr, L. L.; Sharp, T. R.; Snyder, K. D.; Szczesny, E. J. Degradation and Impurity Analysis for Pharmaceutical Drug Candi-dates. In Handbook of Modern Pharmaceutical Analysis; Ahuja, S. Scypinski, S. Eds.; Academic Press: San Diego, USA, 2001; pp. 85–172.
   Google Scholar
• Todd, C.; Sheinin, E. In Handbook of Pharmaceutical Analysis by HPLC; Ahuja, S. Dong, M. Eds.; Academic Press: San Diego, USA, 2005; pp. 359–377.
   Google Scholar
• Zhou, L. Z. In Handbook of Pharmaceutical Analysis by HPLC; Ahuja, S. Dong, M. Eds.; Academic Press; San Diego, USA, 2005; pp. 499–568.
   Google Scholar
• Berridge, J. C. Impurities in Drug Substances and Drug Products: New Approaches to Quantification and Qualification. J. Pharm. Biomed. Anal. 1995, 14, 7–12.
   PubMed Web of Science ®Google Scholar
• Krstulovic, A. M.; Lee, C. R. Defining Drug Purity Through Chromatographic and Related Methods: Current Status and Perspectives. J. Chromatogr. B. 1997, 689, 137–153.
   PubMed Web of Science ®Google Scholar
• Rao, R. N.; Nagaraju, V. An Overview of the Recent Trends in Development of HPLC Methods for Determination of Impurities in Drugs. J. Pharm. Biomed. Anal. 2003, 33, 335–377.
   PubMed Web of Science ®Google Scholar
• Lakshmi, B.; Reddy, T. V. A Novel RP – HPLC Method for the Quantification of Linagliptin in Formulations. J. Atoms. Mol. 2012, 2(2), 155–164.
   Google Scholar
• Indian Pharmacopoeia Govt. of India Ministry of Health & Family Welfare, The Controller of Publication, Vol. 2, 340, pp. 1657–1660.
   Google Scholar
• Goodman, Gilman. The Pharmacological Basis of Therapeutics 10th Ed., Mc Grow Hill Publication, 1686, 1687, 1700.
   Google Scholar
• Rang, H. P.; Dale, M. M.; Ritter, J. M.; Moore, P. K. Pharmacology; 7th Ed.; Elsevier Publication, 2007; p. 372.
   Google Scholar
• Lakshmi, B.; Reddy, T. V. A Noval RP-HPLC Method for the Quantification of Linagliptin in Formulations. Int. J. Atoms Mol. 2012, 2(2), 155–164.
   Google Scholar
• Badugu, L. R. A Validated RP-HPLC Method for Determination of Linagliptin. Am. J. Pharm. Res. 2012, 12, 133–137.
   Google Scholar
• Sekhar, C. K.; Sudhakar, P. A New UV Method for Determination of Linagliptin in Bulk and Pharmaceutical Dosage Form. Int. J. Univ. Pharm. Biosci. 2013, 2, 54–56.
   Google Scholar
• Balasubramanian, J.; Azhagesh, R. K. A Review of Chromatographic Techniques Used in the Analysis of Anti Diabetic Drugs. Discovery Biotechnol. 2012, 1, 05–17.
   Google Scholar
• Ramzia, I.; Bagary, E. L.; Elkady, E. F. Liquid Chromatographic Determination of Linagliptin in Bulk and in Plasma and Its Pharmaceutical Preparation. Int. J. Biomed. Sci. 2012, 8(3), 209–214.
   PubMedGoogle Scholar
• Khan, G.; Sahu, D.; Agrawal, Y. P. An HPLC Method for the Determination of Linagliptin in Bulk Drug and Tablets. Asian J. Biochem. Pharm. Res. 2011, 1, 352–358.
   Google Scholar
• Ahuja, S.; Alsante, K. M. (Eds.). Handbook of Isolation and Characterization of Impurities in Pharmaceuticals, Elsevier: Amsterdam, The Netherlands, 2003.
   Google Scholar
• Husain, S.; Nageswara Rao, R. Monitoring of Process Impurities in Drugs. In Advanced Chromatographic and Electromigration Methods in Biosciences; Deyl, Z. Miksik, I. Tagliero, F. Tesarová, E. Eds.; Elsevier: Amsterdam, The Netherlands, 1998; pp. 833–888.
   Google Scholar
• Rompay, J. V. Purity Determination and Evaluation of New Drug Substances. J. Pharm. Biomed. Anal. 1986, 4, 725–732.
   PubMed Web of Science ®Google Scholar
• Ahuja, S. Assuring Quality of Drugs by Monitoring Impurities. Adv. Drug Deliv. Rev. 2007, 59, 3–11.
   PubMed Web of Science ®Google Scholar
• Ahuja, S. Impurities Evaluation of Pharmaceutical. Marcel Dekker: New York, USA, 1998.
   Google Scholar
• Görög, S. Identification and Determination of Impurities in Drugs. Elsevier: Amsterdam, The Netherlands, 2000.
   Google Scholar
• Webb, M.; Smith, R.; Eds., Analysis of Drug Impurities, Blackwell: Oxford, UK, 2007.
   Google Scholar
• Rahman, N.; Hejaz Azmi, S. N.; Wu, H.-F. The Importance of Impurity Analysis in Pharmaceutical Products: An Integrated Approach, Accred. Qual. Assur. 2006, 11, 69–74.
   Web of Science ®Google Scholar
• Bartos, D.; Görög, S. Recent Advances in the Impurity Profiling of Drugs. Curr. Pharm. Anal. 2008, 4, 215–230.
   Web of Science ®Google Scholar
• Shubhangi, M. P.; Sunil, R. D. Application of Stability Indicating High Performance Thin Layer Chromatographic Method for Quantitation of Pramipexole in Pharmaceutical Dosage Form. J. Liq. Chromatogr. Related Technol. 2011, 34, 1664–1675.
   Web of Science ®Google Scholar
• Yau, Y. L.; Jeffrey, M. S.; Glenn, D. H.; Rasmy, T.; Nita, I. Determination of Pramipexole (U-98,528) in Humanplasma by High-performance Liquid Chromatography with Atmospheric Pressure Chemical Ionization Tandem Mass Spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 1996, 683, 209–216.
   Google Scholar
• Nirogi, R. V.; Kandikere, V.; Shrivastava, W.; Mudigonda, K.; Maurya, S.; Ajjala, D. Quantification of Pramipexole in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry Using Tamsulosin as Internal Standard. Biomed. Chromatogr. 2007, 21, 1151–1158.
   PubMed Web of Science ®Google Scholar
• Yadav, M.; Rao, R.; Kurani, H.; Rathod, J.; Patel, R.; Singhal, P.; Shrivastav, P. S. Validated Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry Method for the Determination of Pramipexole in Human Plasma. J. Chromatogr. Sci. 2010, 48, 811–818.
   PubMed Web of Science ®Google Scholar
• Pathare, D. B.; Jadhav, A. S.; Shingare, M. S. Validated Chiral Liquid Chromatographic Method for the Enantiomeric Separation of Pramipexole Dihydrochloride Monohydrate. J. Pharm. Biomed. Anal. 2006, 16, 1152–1156.
   Web of Science ®Google Scholar
• Jančić, B.; Medenica, M.; Ivanović, D.; Malenović, A. Experimental Design in Chromatographic Analysis of Pramipexole and Its Impurities. Acta Chim. Sloven. 2007, 54, 49–54.
   Web of Science ®Google Scholar
• Yau, Y. L.; Glenn, D. H.; Nita, I. Determination of Pramipexole (U-98,528) in Human Plasma and Urine by High-performance Liquid Chromatography with Electrochemical and Ultraviolet Detection. J. Chromatogr. B: Biomed. Sci. Appl. 1996, 683, 217–223.
   Google Scholar
• Seshagiri Rao, J. V. L. N.; Anantha Kumar, D.; Mastanamma, S.; Srilakshmi, K. Estimation of Pramipexole by an RP-HPLC Method. Int. J. Chem. Sci. 2009, 7, 2789–2794.
   Google Scholar
• Srinubabu, G.; Jaganbabu, K.; Sudharani, B.; Venugopal, K.; Girizasankar, G.; Rao, J. V. L. N. S. Development and Validation of a LC Method for the Determination of Pramipexole using an Experimental Design. Chromatographia 2006, 64, 95–100.
   Web of Science ®Google Scholar
• Lavudu, P.; Prameela Rani, A.; Balashekaran, C.; Venumadhav, V. Rp-Hplc Method for the Determination of Pramipexole Dihydrochloride in Tablet Dosage Form. Global Journal of Medical Research 2012, 12(4).
   Google Scholar
• Nageswara Rao, R.; Sravan, B.; Ramakrishna, K.; Raju, B.; Srinivas, R. LC–MS/MS Determination of Pramipexole on Rat Dried Blood Spots: A Pharmacokinetic Study. J. Chromatogr. B. 2013, 932, 34–39.
   PubMed Web of Science ®Google Scholar
• Jayesh, G. P.; Ravindra, V. P.; Shobhana, K. M. Development and Validation of GC/MS Method for Determination of Pramipexole in Rat Plasma. Biomed. Chromatogr. 2011, 25, 524–530.
   PubMed Web of Science ®Google Scholar
• Bharathi, D. V.; Hotha, K. K.; Sagar, P. V.; Kumar, S. S.; Naidu, A.; Mullangi, R. Development and Validation of a Sensitive LC–MS/MS Method with Electrosprayionization for Quantitation of Pramipexole in Humanplasma: Application to a Clinical Pharmacokinetic Study. Biomed. Chromatogr. 2009, 23, 212–220.
   PubMed Web of Science ®Google Scholar
• Sahoo, P. K.; Sharma, R.; Chaturvedi, S. C. Simultaneous Estimation of Metformin Hydrochloride and Pioglitazone Hydrochloride by RPHPLC Method From Combined Tablet Dosage Form Ind. J. Pharm. Sci. 2008, 70, 383–386.
   PubMed Web of Science ®Google Scholar
• Wanjari, M. M.; Umathe, S. N. Rapid and Simple RPHPLC Method for the Estimation of Metformin in Rat Plasma. Ind. J. Pharm. Sci. 2005, 70(2), 198–202.
   Google Scholar
• Koseki, N.; Kawasita, H. Development and Validation for High Selective Quantitative Determination of Metformin in Human Plasma by Cation Exchanging with Normal-phase LC/MS/MS. J. Pharm. Biomed. Anal. 2007, 36, 1063–1072.
   Web of Science ®Google Scholar
• Pandya, R. H.; et al. Bioanalytical Method Development And Validation For Simultaneous Determination Of Linagliptin And Metformin Drugs In Human Plasma By Rp-Hplc Method. Pharmacophore 2014, 5(2), 202–218. http://www.pharmacophorejournal.com.
   Google Scholar
• Xing, J.; Chunfeng, X.; Hongxiang, L. Recent Applications of Liquid Chromatography-Mass Spectrometry in Natural Products Bio analysis. J. Pharm. Biomed. Anal. 2007, 44, 368–378.
   PubMed Web of Science ®Google Scholar
• Kataoka, H. Recent advances in solid phase microextraction and related techniques for pharmaceutical And biomedical analysis. Curr. Pharm. Anal. 2005, 65–84.
   Web of Science ®Google Scholar
• Hopfgartner, G.; Bourgogne, E. Quantitative High-throughput Analysis of Biological Matrices by Mass Spectrometry. J. Mass Spectrom. 2003, 22, 195–214.
   Web of Science ®Google Scholar
• Snyder, L. R.; Joseph, J. K.; Practical HPLC Method Development; 2nd Ed.; John Wiley & Sons Publication, 2002, 48–69, 175–229, 234–265, 654–660.
   Google Scholar
• Niessen, W. M. A. Liquid Chromatography-Mass Spectrometry; 3rd Ed.; Taylor & Francis: New York, 2006; pp. 290–306
   Google Scholar
• Lakshmi, B.; Reddy, T. V. A Novel RP-HPLC Method for the Quantification of Linagliptin in Formulations. J. Atoms. Mole. 2012, 2(2), 155–164. http://www.iajpr.com
   Google Scholar
• Chin, J.; Fell, J. B.; Jarosinski, M.; Shapiro, M. J.; Wareing, J. R. HPLC/NMR in Combinatorial Chemistry. J. Org. Chem. 1998, 63, 386–390.
   Web of Science ®Google Scholar
• Thiele, H.; McLeod, G.; Niemitz, M.; Kühn, T. Structure Verification of Small Molecules using Mass Spectrometry and NMR Spectroscopy. Monatsh. Chem. 2011, 142, 717–730.
   Web of Science ®Google Scholar
• Bharti, S. K.; Roy, R. Quantitative1H NMR Spectroscopy. Trends Anal. Chem. 2012, 35, 5–26.
   Web of Science ®Google Scholar
• Findeisen, M.; Berger, S. 50 and More Essential NMR Experiments: A Detailed Guide; Wiley: New York, USA, 2013.
   Google Scholar
• Berger, S.; Braun, S. 200 and More NMR Experiments; Wiley: New York, USA, 2004.
   Google Scholar
• Webb, G. A. (Ed.), Modern Magnetic Resonance; Springer: Heidelberg, Germany, 2007.
   Google Scholar
• Keeler, J. Understanding NMR Spectroscopy; Wiley: New York, USA, 2013.
   Google Scholar
• Heise, H.; Matthews, S. (Eds.), Modern NMR Methodology; Springer: Heidel-berg, Germany, 2013.
   Google Scholar
• Jacobsen, N. E. NMR Spectroscopy Explained: Simplified Theory, Applications and Examples for Organic Chemistry and Structural Biology; Wiley: New York, USA, 2007.
   Google Scholar
• Iqbal, M. Y.; Narayana Rao, K. M. V.; Sridhar, G.; Padmanabha Raju, P.; Desh-pande, G. R.; Babu, J. M. Characterization and Relative Response Factor Determination of Process Related Impurity in Naproxen by Nuclear Magnetic Resonance Spectroscopy. J. Pharm. Biomed. Anal. 2011, 56, 484–490.
   PubMed Web of Science ®Google Scholar
• Holzgrabe, U.; Deubner, R.; Schollmayer, C.; Waibel, B. Quantitative NMR Spectroscopy – Applications in Drug Analysis. J. Pharm. Biomed. Anal. 2005, 38, 806–812.
   PubMed Web of Science ®Google Scholar
• Malet-Martino, M.; Holzgrabe, U. NMR Techniques in Biomedical and Pharmaceutical Analysis. J. Pharm. Biomed. Anal. 2011, 55, 1–15.
   PubMed Web of Science ®Google Scholar
• Claridge, D. W. T. High Resolution NMR Techniques in Organic Chemistry; Elsevier: Amsterdam, The Netherlands, 2009.
   Google Scholar
• Ito, S.; Miki, T.; Yoshikawa, M.; Hamada, M.; Kawate, Y.; Hayashi, S.; Sato, A.; Kiyoshi, T.; Matsumoto, F.; Nagai, H.; Wada, H.; Fukui, S.; Noguchi, T. Test Results of Long Term Operation of the Superfluid Cooled Cryostat for a 1 GHz NMR Spectrometer. IEEE Trans. Appl. Supercond. 2002, 12, 1347–1350.
   Web of Science ®Google Scholar
• Flynn, P. F.; Mattiello, D. L.; Hill, H. D. W.; Wand, A. J. Optimal Use of Cryogenic Probe Technology in NMR Studies of Proteins. J. Am. Chem. Soc. 2000, 122, 4823–4824.
   Web of Science ®Google Scholar
• Nagai, H.; Sato, A.; Kiyoshi, T.; Matsumoto, F.; Wada, H.; Ito, S.; Miki, T.; Yoshikawa, M.; Kawate, Y.; Fukui, S. Development and Testing of Superfluid-cooled900 MHz NMR Magnet. Cryogenics 2001, 41, 623–630.
   Web of Science ®Google Scholar
• Song, Y. Q.; Goodson, B. M.; Pines, A. NMR and MRI using Laser-Polarized Xenon. Spectroscopy 1999, 14, 26–33.
   Web of Science ®Google Scholar
• Holzgrabe, U.; Diehl, B.; Wawer, I. (Eds.) NMR Spectroscopy in Pharmaceutical Analysis; Elsevier: Amsterdam, The Netherlands, 2008.
   Google Scholar
• Karioti, A.; Giocaliere, E.; Guccione, C.; Pieraccini, G.; Gallo, E.; Vannaccic, A.; Bilia, A. R. Combined HPLC–DAD–MS, HPLC–MSn and NMR Spectroscopy for Quality Control of Plant Extracts: The Case of a Commercial Blend Sold as Dietary Supplement. J. Pharm. Biomed. Anal. 2014, 88, 7–15.
   PubMed Web of Science ®Google Scholar
• McEwen, I.; Elmsjö, A.; Lehnström, A.; Hakkarainen, A.; Johansson, B. M. Screening of Counterfeit Corticosteroid in Creams and Ointments by NMR Spectroscopy. J. Pharm. Biomed. Anal. 2012, 70, 245–250.
   PubMed Web of Science ®Google Scholar
• Beyer, T.; Diehl, B.; Holzgrabe, U. Quantitative NMR Spectroscopy of Biologically Active Substances and Excipients. Bioanal. Rev. 2010, 2, 1–22.
   Google Scholar
• Görög, S.; Szántay, C.; Jr. Spectroscopic Methods in Drug Quality Control and Development. In Encyclopedia of Spectroscopy and Spectrometry; Lindon, J. Tranter, G. Koppenaal, D. Eds.; Elsevier: Oxford, UK, 2010; Vol. 3, 2nd ed., pp. 2640–2650.
   Google Scholar
• SzántayJr., C.; Béni, Z.; Balogh, G.; Gáti, T. The Changing Role of NMR Spectroscopy in Off-line Impurity Identification: A Conceptual View. Trends Anal. Chem. 2006, 25, 806–820.
   Web of Science ®Google Scholar
• SzántayJr., C.; Demeter, A. NMR Spectroscopy. In Identification and Determination of Impurities in Drugs; Görög, S. Ed.; 1st ed., Elsevier: Amsterdam, The Netherlands, 2000; pp. 109–143.
   Google Scholar
• Aranyi, A. Isolation of Impurities by (semi)preparative HPLC. In Identification and Determination of Impurities in Drugs; Görög, S., Ed.; Elsevier; Amsterdam, The Netherlands, 2000; 1st ed., pp. 240–251.
   Google Scholar
• Pauli, G. F.; Gödecke, T.; Jaki, B. U.; Lankin, D. C. Quantitative1H NMR. Development and Potential of An Analytical Method: An Update. J. Nat. Prod. 2012, 75, 834–851.
   PubMed Web of Science ®Google Scholar
• Ründlof, T.; McEwen, T. R.; Johansson, M.; Arvidsson, T. Use and Qualification of Primary and Secondary Standards Employed in Quantitative1HNMR Spectroscopy of Pharmaceuticals. J. Pharm. Biomed. Anal. 2013, 93, 111–117.
   PubMed Web of Science ®Google Scholar
• Weber, M.; Hellriegel, C.; Rück, A.; Wuethrich, J.; Jenks, P. Using High-performance1H NMR (HP-qNMR®) for the Certification of Organic Reference Materials Under Accreditation Guidelines – Describing the Overall Process with Focus on Homogeneity and Stability Assessment. J. Pharm. Biomed. Anal. 2013, 007. http://dx.doi.org/10.1016/j.jpba.2013.09.
   PubMed Web of Science ®Google Scholar
• Jancke, H.; Malz, F.; Haesselbarth, W. Structure Analytical Methods for Quantitative Reference Applications. Accred. Qual. Assur. 2005, 10, 421–429.
   Web of Science ®Google Scholar
• Schoenberger, T. Determination of Standard Sample Purity Using the High-Precision1H-NMR Process. Anal. Bioanal. Chem. 2012, 403, 247–254.
   PubMed Web of Science ®Google Scholar
• Malz, F.; Jancke, H. Validation of Quantitative NMR. J. Pharm. Biomed. Anal. 2005, 38, 813–823.
   PubMed Web of Science ®Google Scholar
• Holzgrabe, U. Quantitative NMR Spectroscopy in Pharmaceutical Applications. Prog. Nucl. Magn. Reson. Spectrosc. 2010, 57, 229–240.
   PubMed Web of Science ®Google Scholar
• Mahajan, S.; Singh, I. P. Determining and Reporting Purity of Organic Molecules: Why qNMR. Magn. Reson. Chem. 2013, 51, 76–81.
   PubMed Web of Science ®Google Scholar
• Nogueira, R.; Garrido, B. C.; Borges, R. M.; Silva, G. E. B.; Queiroz, S. M.; Cunha, V. S. Development of A New Sodium Diclofenac Certified Reference Material Using the Mass Balance Approach and1H qNMR to Determine the Certified Property Value. Eur. J. Pharm. Sci. 2013, 48, 502–513.
   PubMed Web of Science ®Google Scholar
• Weber, M.; Hellriegel, C.; Rück, A.; Sauermoser, R.; Wüthrich, J. Using High-performance Quantitative NMR (HP-qNMRW) for Certifying Traceable and Highly Accurate Purity Values of Organic Reference Materials with Uncertain-ties < 0.1%. Accred. Qual. Assur. 2013, 18, 91–98.
   Web of Science ®Google Scholar
• Holzgrabe, U. Quantitative NMR Spectroscopy in Pharmaceutical Applications. Progr. NMR Spectrosc. 2010, 57, 229–240.
   PubMed Web of Science ®Google Scholar
• Deubner, R.; Holzgrabe, U. Micellar Electrokinetic Capillary Chromatography, High Performance Liquid Chromatography and Nuclear Magnetic Resonance-three Orthogonal Methods for Characterization of Critical Drugs. J. Pharm. Biomed. Anal. 2004, 35, 459–467.
   PubMed Web of Science ®Google Scholar
• Albert, K. (Ed.), On-Line LC–NMR and Related Techniques; Wiley: New York, USA, 2002.
   Google Scholar
• Silva Elipe, M. V. LC–NMR and Other Hyphenated NMR Techniques: Overview and Applications; Wiley: Hoboken, USA, 2012.
   Google Scholar
• Kazakevich, Y.; LoBrutto, R. (Eds.), HPLC for Pharmaceutical Scientists; Wiley: New York, USA, 2007; pp. 901–936.
   Google Scholar
• Gonella, N. C. LC–NMR: Expanding the Limits of Structure Elucidation; CRC: Boca Raton, USA, 2013.
   Google Scholar
• Wann, M.-H. 20 Application of LC–NMR in Pharmaceutical Analysis. Sep. Sci. Technol. 2005, 6, 569–579.
   Google Scholar
• Kesting, J. R.; Johansen, K. T.; Jaroszewski, J. W. Hyphenated NMR Techniques. In Advances in Biomedical Spectroscopy, Volume3: Biomolecular NMR Spectroscopy; Dingley, A. J. Pascal, S. M. Eds.; IOP Press: Amsterdam, The Netherlands, 2011, pp. 413–434.
   Google Scholar
• Kühnle, M.; Kreidler, D.; Czesla, H.; Holtin, K.; Schuler, P.; Schaal, W.; Schurig, V.; Albert, K. On-line Coupling of Gas Chromatography to Nuclear Magnetic Resonance Spectroscopy: A Method for the Analysis of Volatile Stereoisomers. Anal. Chem. 2008, 80, 5481–548.
   PubMed Web of Science ®Google Scholar
• Grynbaum, M.; Kreidler, D.; Rehbein, J.; Purea, A.; Schuler, P.; Schaal, W.; Czesla, H.; Webb, A.; Schurig, V.; Albert, K. Hyphenation of Gas Chromatography to Micro-coil1H Nuclear Magnetic Resonance Spectroscopy. Anal. Chem. 2007, 79, 2708–2713.
   PubMed Web of Science ®Google Scholar
• Pusecker, K.; Schewitz, J.; Gfrorer, P.; Tseng, L.-H.; Albert, K.; Bayer, E.; Wilson, I. D.; Bailey, N. J.; Scarfe, G. B.; Nicholson, J. K.; Lindon, L. C. On-flow Identification of Metabolites of Paracetamol from Human Urine using Directly Coupled CZE-NMR and CEC-NMR Spectroscopy. Anal. Commun. 1998, 35, 213–215.
   Google Scholar
• Schewitz, J.; Gfrorer, P.; Pusecker, K.; Tseng, L.-H.; Albert, K.; Bayer, E.; Wilson, I. D.; Bailey, N. J.; Scarfe, G. B.; Nicholson, J. K.; Lindon, J. C. Directly Coupled CZE-NMR and CEC-NMR Spectroscopy of Metabolite Analysis: Paracetamol Metabolitesin Human Tissue. Analyst 1998, 12, 2835–2837.
   Web of Science ®Google Scholar
• Pusecker, K.; Schewitz, J.; Gfrorer, P.; Tseng, L.-H.; Albert, K.; Bayer, E. On-line coupling of Capillary Electrochromatography, Capillary Electrophoresis, and Capillary HPLC with Nuclear Magnetic Resonance Spectroscopy. Anal. Chem. 1998, 70, 3280–3285.
   PubMed Web of Science ®Google Scholar
• Gfrorer, P.; Tseng, L.-H.; Rapp, E.; Albert, K.; Bayer, E. Influence of Pressure Upon Coupling Pressurized Capillary Electrochromatography with Nuclear Magnetic resonance Spectroscopy. Anal. Chem. 2001, 73, 3234–3239.
   PubMed Web of Science ®Google Scholar
• Gfrorer, P.; Schewitz, J.; Pusecker, K.; Tseng, L.-H.; Albert, K.; Bayer, E. Gradient Elution Capillary Electrochromatography and Hyphenation with Nuclear Magnetic Resonance. Electrophoresis 1999, 20, 3–8.
   PubMed Web of Science ®Google Scholar
• Little, M. J.; Aubry, N.; Beaudoin, M.-E.; Goudreau, N.; LaPlante, S. R. Quantifying Trifluoroacetic Acid as a Counterion in Drug Discovery by 19F NMR and Capillary Electrophoresis. J. Pharm. Biomed. Anal. 2007, 43, 1324–1330.
   PubMed Web of Science ®Google Scholar
• Alessandro, M.; Ernst, K.; Emanuele, M.; Fabrizio, R.; Maria, A. R. Analysis of the Anti-Parkinson Drug Pramipexole in Human Urine by Capillary electrophoresis with Laser-induced Fluorescence Detection. Anal. Chim. Acta. 2008, 626, 89–96.
   PubMed Web of Science ®Google Scholar
• Stefan, B.; Schwellinger, E. The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans. Am. Soc. Pharm. Exp. Ther. 2010, 38, 667–678.
   Google Scholar
• Archana, M.; Sriram, N.; Gayasuddin, Md. Method Development and Validation of RP-HPLC Method for Determination of New Antidiabetic Agent Linagliptin in Bulk and in Pharmaceutical Formulation. Int. J. Med. Chem. Anal. 2013, 3(1), 1–5.
   Google Scholar
• El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Liquid Chromatographic Determination of Linagliptin in Bulk, in Plasma and in its Pharmaceutical Preparation. Int. J. Biomed. Sci. 2012, 8(3), 209–214.
   PubMedGoogle Scholar
• Lakshman Raju, B. A Validated RP-HPLC Method for the Determination of Linagliptin. Am. J. Pharm. Tech. Res. 2012, 2(4), 462–470.
   Google Scholar
• Janardhan Swamy, A.; Harinadha Baba, K. Analytical Method Development and Method Validation for the Simultaneous Estimation of Metformin HCl and Linagliptin in Bulk and Tablet Dosage Form by RP-HPLC Method. Int. J. Pharm. 2013, 3(3), 594–600.
   Google Scholar
• Dhyaneshwar, T.; Patil, V.; Kalkotwar, R.; Jadhav Vijay, B.; Chandra Sekhar, K. A New RP–HPLC Method for Simultaneous Estimation of Metformin HCl and Linagliptin in Tablet Dosage Form. World J. Pharm. Pharm. Sci. 2013, 2(3), 1332–1341.
   Google Scholar
• Dilip Patil, A.; Vishal Patil, A.; Sanjay Bari, B. Development and Validation of RP-HPLC Method for the Analysis of Linagliptin. Inventi Rapid: Pharm. Anal. Qual. Assur. 2013; Article ID Inventi:ppaqa/598/12 ”, [cited 2013 Sep 26] Available From http://www.inventi.in/Article/ppaqa/598/12.aspx
   Google Scholar
• Sukumar, N.; Akkina, N.; Gona Bala Narashimha Reddy; Paparaju, V.; Syam Prasad Reddy, A.; Shantan Kumar Reddy, K. Chemical Research and Development, Aurobindo Pharma Limited, Andhra Pradesh-502329. J. Pharma. Res. Opin. Process Related Impurit. Anti-Diabetic Drug Linagliptin India. ISSN no : 2249–1953.
   Google Scholar
• Székely, Gy.; Henriques, B.; Gil, M.; Ramos, A.; Alvarez, C. Design of Experiments as a Tool for LC–MS/MS Method Development for the Trace Analysis of the Potentially Genotoxic 4-dimethylaminopyridine Impurity in Glucocorticoids. J. Pharm. Biomed. Anal. 2012, 70, 251–258.
   PubMed Web of Science ®Google Scholar